Anti-XIAP (MIHA/ILP-a) (Human) mAb
Code | Size | Price |
---|
MBL-M044-3 | 100 ug | £341.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 2F1
Regulatory Status: RUO
Target Species:
- Human
- Mouse
- Rat
Applications:
- Immunohistochemistry (IHC)
- Western Blot (WB)
Shipping:
4°C
Storage:
-20°C
Images
Documents
Further Information
Applications:
WB - 1 ug/mL (chemiluminescence detection system)
Background:
Caspase, related to ICE and to CED-
3, play central roles as effectors of apoptosis. Ablation of
caspase activity is attained by p35 from baculovirus and
CrmA from cowpox, which appear to be suicide
inactivators, strongly inhibiting caspase activity.
Overexpression of there caspase inhibitors in insect,
nematoda and mammalian cells results in resistance to
apoptotic stimuli, demonstrating that components of the
apoptotic pathway are highly conserved throughout
evolution, and leading to the speculation that mammalian
functional equivalents of these protease inhibitors may
exist. The inhibitor of apoptosis proteins (IAPs) are a
family of anti-apoptotic proteins that are conserved across
species. Four IAPs have been identified in mammal; NAIP,
cIAP1/HIAP2/hMIHB, cIAP2/HIAP1/hMIHC, XIAP/hILP.
A prototype of the human IAPs is the XIAP, with a 1.5 kb
coding region corresponding to a 55 kDa protein. XIAP can
directly inhibit two members of the cell death protease
family, caspase-3 and -7.
Concentration:
1 mg/mL
Formulation:
1.0 mg/mL in PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 331 Mouse: 11798
Immunogen Translated:
Full-length recombinant human XIAP protein
Reactivity:
This antibody reacts with XIAP on
Western blotting. 2F1 recognizes C-terminal region of
XIAP (352-449 aa) and detects 55 kDa of XIAP on Western
Blot using total cell lysate from human or mouse cell line,
for example, Jurkat, Raji, NIH/3T3, etc.
Shelf Life:
1 year
Source:
This antibody was purified from hybridoma (clone 2F1) supernatant
using protein A agarose. This hybridoma
was established by fusion of mouse myeloma cell P3U1
with Balb/c mouse splenocyte immunized with the full
length recombinant XIAP protein (1-497 aa).
Target:
XIAP
References
1) Cillessen, S. A., et al., Clin. Cancer Res. 13, 7012-7021 (2007)
2) Marsden, V. S., et al., Blood 107, 1872-1877 (2006)
3) Tanaka, H., et al., J. Biol. Chem. 280, 40965-40973 (2005)
4) Muris, J.J., et al., Blood 105, 2916-2923 (2005)
5) Silke, J., et al., PNAS. 102, 16182-16187 (2005)
6) Silke, J., et al., J. Biol. Chem. 279, 4313-4321 (2004)
7) Park, S-J., et al., J. Biol. Chem. 279, 51057-51067 (2004)
8) Ferreira, C. G., et al., Clin. Cancer Res. 7, 2468-2474 (2001)
9) Ferreira, C. G., et al., Ann. Onc. 12, 799-805 (2001)
10) Li, J., et al. Endocrinology 139, 1321-1328 (1998)
11) Farahani, R., et al. Genomics 42, 514-518 (1997)
12) Roy, N., et al., EMBO J. 16, 6914-6925 (1997)
13) Deveraux, QL., et al. Nature 388, 300-304 (1997)
14) Liston, P., et al. Nature 379, 349-353 (1996)